| |
|
|
|
Oasmia Pharmaceutical AB (publ)  
|
|
2.46 0.02 (0.01%) |
02-19 16:00 |
|
Open: |
2.516 |
Pre close: |
2.44 |
Target:
|
3.43
|
|
High: |
2.4656 |
Low: |
2.43 |
Resistance:
|
2.94
3.40
|
|
Volume: |
892 |
Market Cap: |
173M |
Support:
|
2.20
1.83
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.41
 |
MACD |
MACD(12,26):
|
-0.19  |
|
MA(20): |
2.55 |
Signal(12,26,9): |
-0.20 |
|
MA(100): |
3.61 |
Stochastic Oscillator |
%K(14,3):
|
40.13 |
|
MA(250): |
2.41 |
%D(3): |
33.89 |
|
Average Volume(K) |
3-Month: |
946
|
52-Week |
High:
|
5.70 |
|
10-Days: |
309 |
Low: |
1.20 |
|
RSI |
RSI(14):
|
37.40 |
Change(%): |
73.6 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-38.6 |
Shares Out. (M) |
67.32 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-26.3 |
Shares Float (M) |
67.32 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
10.1 |
% Held by Institutions |
0.10 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
3.860 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.64 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
